Jason Helfstein, Oppenheimer head of internet research, joins 'The Exchange' to discuss Spotify as the stock sinks on Q2 revenue miss.

Shares of Sarepta Therapeutics surged Tuesday morning after the company said it had been informed by the Food and Drug Administration that it could resume shipping a drug it paused sales of last week.

The strategist — an industry veteran of 40 years who joined Goldman Sachs in 2002 — spoke to Bloomberg News about the outlook ...

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...

Carvana Co. (NYSE:CVNA) is one of the best multibagger stocks according to hedge funds. On July 25, 2025, Oppenheimer analyst ...

This isn’t a generic re-run. These screenings are a testament to Nolan’s continued support for the IMAX format and enable ...

Jensen Huang believes questions of whether artificial intelligence (AI) could destroy humanity are fear-mongering — and get ...

The S&P 500 could match its best set of annual gains in three decades this year, analysts at Oppenheimer Asset Management say, as the tailwind from trade deals and improved corporate earnings carries ...

Trump's trade deals with the EU and Japan pave the way for the stock market to end with it's third straight annual gain of ...

Just a few years before 2023’s Barbenheimer phenomenon, Margot Robbie starred in a complex biopic that was much Oppenheimer ...

Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major ...

Speaker Javier Martinez stops to check out the 1947 Plymouth Deluxe parked by the Oppenheimer House with District 43 Rep.